• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于阳性和阴性症状量表(PANSS)及精神分裂症症状评定量表(SAPS)/精神分裂症阴性症状评定量表(SANS)结果的精神分裂症结构核心因素。PANSS与SAPS/SANS效度的辨别及直接比较]

[Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].

作者信息

Masiak Marek, Loza Bartosz

机构信息

Katedry i Kliniki Psychiatrii AM w Lublinie

出版信息

Psychiatr Pol. 2004 Sep-Oct;38(5):795-808.

PMID:15523927
Abstract

AIM

A lot of inconsistencies across dimensional studies of schizophrenia(s) are being unveiled. These problems are strongly related to the methodological aspects of collecting data and specific statistical analyses. Psychiatrists have developed lots of psychopathological models derived from analytic studies based on SAPS/SANS (the Scale for the Assessment of Positive Symptoms/the Scale for the Assessment of Negative Symptoms) and PANSS (The Positive and Negative Syndrome Scale). The unique validation of parallel two independent factor models was performed--ascribed to the same illness and based on different diagnostic scales--to investigate indirect methodological causes of clinical discrepancies.

METHOD

100 newly admitted patients (mean age--33.5, 18-45, males--64, females--36, hospitalised on average 5.15 times) with paranoid schizophrenia (according to ICD-10) were scored and analysed using PANSS and SAPS/SANS during psychotic exacerbation. All patients were treated with neuroleptics of various kinds with 410mg equivalents of chlorpromazine (atypicals:typicals --> 41:59). Factor analyses were applied to basic results (with principal component analysis, normalised varimax rotation). Investing the cross-model validity, canonical analysis was applied.

RESULTS

Models of schizophrenia varied from 3 to 5 factors. PANSS model included: positive, negative, disorganisation, cognitive and depressive components and SAPS/SANS model was dominated by positive, negative and disorganisation factors. The SAPS/SANS accounted for merely 48% of the PANSS common variances. The SAPS/SANS combined measurement preferentially (67% of canonical variance) targeted positive-negative dichotomy. Respectively, PANSS shared positive-negative phenomenology in 35% of its own variance. The general concept of five-dimensionality in paranoid schizophrenia looks clinically more heuristic and statistically more stabilised.

摘要

目的

精神分裂症维度研究中存在诸多不一致之处。这些问题与数据收集的方法学方面以及特定的统计分析密切相关。精神科医生基于阳性症状评定量表/阴性症状评定量表(SAPS/SANS)和阳性与阴性症状量表(PANSS)开展了大量源自分析性研究的精神病理学模型。对平行的两个独立因素模型进行了独特的验证——归因于同一种疾病且基于不同的诊断量表——以探究临床差异的间接方法学原因。

方法

对100例新入院的偏执型精神分裂症患者(根据国际疾病分类第10版,平均年龄33.5岁,年龄范围18 - 45岁,男性64例,女性36例,平均住院5.15次)在精神病性发作期使用PANSS和SAPS/SANS进行评分和分析。所有患者均接受了各种抗精神病药物治疗,氯丙嗪等效剂量为410mg(非典型药物:典型药物比例为41:59)。对基本结果应用因子分析(采用主成分分析、归一化方差最大化旋转)。为研究交叉模型效度,应用典型相关分析。

结果

精神分裂症模型的因素数量从3个到5个不等。PANSS模型包括:阳性、阴性、紊乱、认知和抑郁成分,而SAPS/SANS模型以阳性、阴性和紊乱因素为主。SAPS/SANS仅占PANSS共同方差的48%。SAPS/SANS联合测量优先针对阳性 - 阴性二分法(占典型方差的67%)。相应地,PANSS在其自身方差的35%中共享阳性 - 阴性现象学。偏执型精神分裂症的五维度总体概念在临床上看起来更具启发性,在统计学上更稳定。

相似文献

1
[Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].[基于阳性和阴性症状量表(PANSS)及精神分裂症症状评定量表(SAPS)/精神分裂症阴性症状评定量表(SANS)结果的精神分裂症结构核心因素。PANSS与SAPS/SANS效度的辨别及直接比较]
Psychiatr Pol. 2004 Sep-Oct;38(5):795-808.
2
[A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].基于阳性和阴性症状量表(PANSS)因子结构的慢性精神分裂症四维模型。对153例慢性精神分裂症患者的研究及与简明精神病评定量表(BPRS)因子结构的比较
Encephale. 1997 Jan-Feb;23(1):10-8.
3
[Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].精神分裂症中的自评量表:偏执-抑郁量表(PD-S)、法兰克福自我感觉量表(FBS)及两个视觉模拟量表的效度评估
Psychiatr Pol. 2003 Mar-Apr;37(2):293-314.
4
[Clinical assessment of schizophrenic syndrome (CASS): validity evaluation of the new diagnostic tool].[精神分裂症综合征的临床评估(CASS):新诊断工具的效度评估]
Psychiatr Pol. 2000 Mar-Apr;34(2):203-21.
5
[Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients].[阳性和阴性症状量表(PANSS)在西班牙精神分裂症患者样本中的效度验证]
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1994 Jul-Aug;22(4):171-7.
6
Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia.异常预测误差与精神分裂症的阴性和抑郁症状相关。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):116-23. doi: 10.1016/j.pnpbp.2007.07.021. Epub 2007 Aug 3.
7
[The PANSS (Positive And Negative Symptom) Scale].[阳性与阴性症状量表(PANSS)]
Encephale. 1997 Apr;23 Spec No 2:35-8.
8
[The factor structure of schizophrenic symptoms: which model is supported by independent item analysis?].[精神分裂症症状的因素结构:独立项目分析支持哪种模型?]
Turk Psikiyatri Derg. 2008 Summer;19(2):141-8.
9
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
10
The Positive and Negative Syndrome Scale--Spanish adaptation.阳性与阴性症状量表——西班牙语改编版。
J Nerv Ment Dis. 1990 Aug;178(8):510-7.

引用本文的文献

1
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).COSMIN对阳性和阴性症状量表(PANSS)测量属性的系统评价与Meta分析。
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
2
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia.精神分裂症患者中阳性和阴性症状量表(PANSS)的马德因子解及其他因子模型的COSMIN综述。
Schizophrenia (Heidelb). 2025 Mar 31;11(1):51. doi: 10.1038/s41537-025-00600-6.
3
Effectiveness and tolerability of warm-supplementing kidney yang added to risperidone in improving cognitive impairment in patients with schizophrenia: An 8-week, multicenter, randomized, double-blind, placebo-controlled clinical trial.
补肾阳方联合利培酮改善精神分裂症患者认知功能障碍的有效性和耐受性:一项为期8周的多中心、随机、双盲、安慰剂对照临床试验。
Curr Ther Res Clin Exp. 2008 Apr;69(2):104-17. doi: 10.1016/j.curtheres.2008.04.008.